Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Bevan

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Genomics|September 2, 2009
The role of androgen receptor mutations in prostate cancer progressionG N Brooke, C L Bevan
Current Cancer Drug Targets|November 11, 2008
Notch signaling: a potential therapeutic target in prostate cancerM A Villaronga, C L Bevan, B Belandia
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1997
Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndromeC L Bevan, I A Hughes, M N Patterson
Oncogene|November 27, 2007
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expressionG N Brooke, M G Parker, C L Bevan
British Journal of Cancer|May 2, 2013
Circulating microRNAs as potential new biomarkers for prostate cancerA Sita-Lumsden, D A Dart, J Waxman, et al.
Journal of Molecular Endocrinology|April 18, 2014
Revising the role of the androgen receptor in breast cancerF M Fioretti, A Sita-Lumsden, C L Bevan, et al.
Molecular and Cellular Biology|November 24, 1999
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1C L Bevan, S Hoare, F Claessens, et al.
Oncogene|October 6, 2009
HEY1 Leu94Met gene polymorphism dramatically modifies its biological functionsM A Villaronga, D N Lavery, C L Bevan, et al.
Oncogenesis|May 16, 2017
The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cellsS Koushyar, G Economides, S Zaat, et al.
Endocrine-Related Cancer|March 19, 2004
Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostateS M Powell, V Christiaens, D Voulgaraki, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Genomics|September 2, 2009
The role of androgen receptor mutations in prostate cancer progressionG N Brooke, C L Bevan
Current Cancer Drug Targets|November 11, 2008
Notch signaling: a potential therapeutic target in prostate cancerM A Villaronga, C L Bevan, B Belandia
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1997
Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndromeC L Bevan, I A Hughes, M N Patterson
Oncogene|November 27, 2007
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expressionG N Brooke, M G Parker, C L Bevan
British Journal of Cancer|May 2, 2013
Circulating microRNAs as potential new biomarkers for prostate cancerA Sita-Lumsden, D A Dart, J Waxman, et al.
Journal of Molecular Endocrinology|April 18, 2014
Revising the role of the androgen receptor in breast cancerF M Fioretti, A Sita-Lumsden, C L Bevan, et al.
Molecular and Cellular Biology|November 24, 1999
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1C L Bevan, S Hoare, F Claessens, et al.
Oncogene|October 6, 2009
HEY1 Leu94Met gene polymorphism dramatically modifies its biological functionsM A Villaronga, D N Lavery, C L Bevan, et al.
Oncogenesis|May 16, 2017
The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cellsS Koushyar, G Economides, S Zaat, et al.
Endocrine-Related Cancer|March 19, 2004
Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostateS M Powell, V Christiaens, D Voulgaraki, et al.
Pageof 3